Thromboembolieprophylaxe mit dalteparin-Na (Fragmin®) bei onkologischen patienten nach port-implantationen

Translated title of the contribution: Thromboembolic prophylaxis with dalteparin-Na (Fragmin®) in oncological patients following port implantations

Christian Lersch, W. Kotowa, D. Janssen

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Thromboembolic prophylaxis with dalteparin-Na (Fragmin®) in oncological patients following port implantations'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science